GBI Research found that the adult and adolescent vaccines market in the top seven markets was valued at $7.2 billion in 2011, increasing at a Compound Annual Growth Rate (CAGR) of 6.9% during the 2007-2011 historic period. The market is projected to witness a growth of 5.6% during the 2011-2018 forecast period to reach $10.5 billion. The growth in the adult and adolescent vaccines market is driven by increased uptake of pneumococcal vaccines such as Prevnar 13 which got approved for use in people aged 50 and older. The pneumococcal vaccines market is expected to grow at a CAGR of 19% during the forecast period and reach $1.7 billion in 2018, from $0.5 billion in 2011. View full report with TOC: http://www.reportsandintelligence.com/adult-and-adolescent-vaccines-to-2018-promising-novel-candidates-in-late-stage-development-and-prevnar-approval-for-use-in-adults-to-drive-growth-market
Global meningococcal vaccines market size is expected to reach $5.69 Bn by 2028 at a rate of 9.6%, segmented as by vaccine type, meningococcal conjugate vaccine, polysaccharide, subcapsular vaccine
Vaccines can be defined as a product that stimulates a persons immune system to produce immunity to a specific disease, thereby protecting the person from that disease. Browse full report @ http://bit.ly/18nvh8U
As per the latest research by PMR, the global meningococcal vaccine market is estimated to account for ~ US$ 6.5 billion in terms of revenue by the end of 2029.
The outbreak of meningococcal meningitis is a severe public health concern and while effective and affordable treatment options are available in the global market, the disease has been found to induce a high rate of mortality and create long-term neurological defects in infants and young children. 50% of bacterial meningitis cases are found in children below five years of age.
P r o t e c t i n g l i f e r i g h t f r o m t h e s t a r t ... P r o t e c t i n g l i f e r i g h t f r o m t h e s t a r t. Recombivax. HB. 1,200 ...
Industry Experts unveiled the new market research report on Influenza. The new global report ‘Global Influenza Market – Vaccines and Therapeutics’ reveals that the market for seasonal influenza vaccines is estimated at 543 million doses valued at US$4.9 billion in 2016 and projected to touch US$714 million doses equated to US$7.9 billion by 2022. In terms of market value, North America is estimated the largest market with US$2.1 billion in 2016 while Europe is projected to be the fastest growing market for Influenza vaccines during the analysis period 2016-2022 with a CAGR of 11.7%. Hyderabad, India based Industry Experts is a multi industry focused business information provider. For more details, please visit http://industry-experts.com/verticals/healthcare-and-pharma/global-influenza-market-vaccines-and-therapeutics
The global Respiratory Disease Vaccine market size grew from $68.4 billion in 2023 to $69.99 billion in 2024 at a compound annual growth rate (CAGR) of 2.3%.
Global Influenza Market is expected to grow at CAGR of 3.4% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Influenza Market.
Bharat Book presents the report on “Global Markets for Vaccine Technologies” (https://www.bharatbook.com/healthcare-market-research-reports-168817/global-vaccine-technologies.html). This report explores present and future strategies within the vaccine technology market, which is divided into vaccines for both humans and animals.
The Pertussis market report thoroughly examines the market size, latest trends, and growth forecast. The report includes an overview of the disease and market scenario, as well as market trends, growth prospects, investment opportunities, and industry prospects. Additionally, it provides competitor analysis, regional analysis, and recent advancements in the Pertussis market.
Nasal drug has been extensively used and due to its efficacy its popularity is rising. Research and development has helped in making it more effective with less and less harm. This report talks about different market aspect of Nasal Drug Delivery Technology. Market drivers that can affect its growth and Delvens' analyst view on this market.
Transition from Childhood (dependence) to Adulthood ... mia: bulimia ... Downloading movies? Do you know what they are doing online? Do you know what they ...
Bharat Book Presents"Global Vaccine Market Forecast to 2017" provides an extensive research and in-depth analysis of the current status and future outlook of the global vaccine market.
Clinical evaluation alone can involve a dozen interlocking trials of different ... Goal is to provide 'robust and compelling evidence' for net clinical benefit ...
Non-profit enterprises created to accelerate R&D for new ... Biomedical Primate Research Center, the Netherlands. Case Western Reserve University, U.S. ...
* NACI Recommendation Adolescent Vaccination Meningococcal C conjugate or quadrivalent conjugate vaccines can be used depending on epidemiology and other ...
... be obtained by just mixing existing monovalent or smaller combination vaccines ... evaluation, no indication of increased reactogenicity vs monovalent vaccines ...
Causes bacterial meningitis in paediatric population(20 - 30%) Long term sequella of meningitis (mental retardation) ... 20% reduction of bacterial pneumonia ...
2nd NVAC Workshop on Strengthening the Supply of Vaccines in the United States ... Endorse the Vaccine Management Business Improvement Project as a mechanism for ...
Invasive meningococcal disease (IMD) is a life-threatening condition caused by the bacterium Neisseria meningitidis (N. meningitidis), an encapsulated gram-negative diplococcus that is a pathogen exclusive to humans. N. meningitidis is carried harmlessly in the nasopharynx of approximately 5?11% of adults and up to 25% of adolescents. Life-threatening disease occurs when the bacterium invades body tissue, which most commonly manifests as meningitis or septicemia. The disease is transmitted via respiratory droplets, through close or prolonged contact with an infected individual. N. meningitidis is classified into 13 distinct serogroups; however, almost all invasive disease in humans is a result of infection with one of 6 serogroups.
Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination report published by Renub Research. According to this report, Sweden is having the highest seasonal influenza vaccine market share. In terms of children vaccination, Sweden & Denmark hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 60 percent market share by 2022. Download full Report: http://www.renub.com/nordics-seasonal-influenza-vaccine-market-forecast-in-denmark-finland-iceland-norway-and-sweden-by-child-and-adult-vaccination-1041-p.php
Pharmaion Consultants offers latest market research report- "United States Lipid Panel Testing Market Opportunities, 2010 - 2020” & studies the market size and share of various segments and sub-segments of the lipid panel testing market in the United States during the period 2010 - 2020.
Canadian Paediatric Society recommends that Canadian children be ... Department of Paediatrics & Adolescent Medicine, Princess. Margaret Hospital, Hong Kong ...
Quality assurance and the US health care system. About NCQA. Documented ... Flu Shots for Adults 3,500 - 7,300. Colorectal Cancer Screening 4,200 - 6,300 ...
Adolescent Addiction Course, Module 2 ... William Blake. At breakfast that morning I had been struck by the lively dissonance of the flower's colours. ...
Aplonis Healthcare is a pediatric PCD pharma company that has established itself as a leading player in the field of pharmaceuticals. The company is known for its commitment to providing high-quality and affordable medicines for infants, children, and adolescents across India. Their extensive range of products includes antibiotics, analgesics, cough syrups, anti-allergy drugs, and much more.
Student / Instructor Orientation Welcome to Aurora Health Care and the Aurora Oshkosh / Fond du Lac Patient Service Market We hope your clinical or internship ...
Current formulations on the Market today are Harsh on the skin and damaging ... These ingredients gently exfoliate your skin, unplug your pores, attack acne ...
HEALTH REFORM and VACCINES: Review of Federal Legislation The Patient Protection and Affordable Care Act (PPACA) And The Health Care and Education Reconciliation Act
Considering the flooding in of cheap, sub-standard drugs into the market, more ... WHO supplies pilot sites in Somalia with drugs, manuals, diagnostic flow charts, ...
divers groupes de la population: les enfants, les adolescents, les hommes, les femmes, les a n s, les anciens combattants, les Autochtones, et les non Canadiens ...
Urge public and private health plans provide adult immunization benefits ... Should help to improve transparency of the funding decision-making process ...
... Produce enough vaccine to immunize the world's population (6.7 billion) ... the series of the vaccine candidate for children are sorbitol based, there is no ...
... success with the smallpox eradication program by the ... it branched out to include polio and measles. before most programs included BCG, smallpox and DPT ...
Sanofi responsible for manufacturing. NSC responsible for distribution & marketing ... transfer of technology of the first generation vaccine as a licensing agreement ...
Ethical, Social, and Good Clinical Practice (GCP) Aspects Of Drug Development In Children And In Paediatric Clinical Trials Klaus Rose, klausrose Consulting
Shingles ... Live Zoster (Shingles) Vaccine. Should NOT be administered ... who have had a previous episode of shingles. Zostavax Pre-licensure trials ...
... Health (CDMH) in June 2003 was accepted as advice in moving ... Provides medical, scientific, and public health advice on vaccine use in Canada. PWGSC ...
... doses per year* IAVI demand forecasting; Policy Research Working Paper # 15, ... The study reviewed national, not sub-national or provincial, public sector data. ...
Is a contagious disease of animals caused by viruses that normally infect only ... make some domestic birds (chickens, ducks and turkeys) very sick and kill them ...